Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan van Lunzen

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
Clinical Immunology (Orlando, Fla.)|May 10, 2003
The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDSMathias Lichterfeld, Hans Dieter Nischalke, Jan van Lunzen, et al.
Cytometry. Part B, Clinical Cytometry|December 16, 2015
Parallel assessment of Th17 cell frequencies by surface marker co-expression versus ex vivo IL-17 production in HIV-1 infectionGábor A Dunay, Ilona Tóth, Johanna M Eberhard, et al.
Plos One|June 19, 2010
Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patientsClara Lehmann, Mark Lafferty, Alfredo Garzino-Demo, et al.
The American Journal of Gastroenterology|June 30, 2005
Decline in esophageal candidiasis and use of antimycotics in European patients with HIVAmanda Mocroft, Cristina Oancea, Jan van Lunzen, et al.
AIDS (London, England)|November 5, 2008
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?Joanne Reekie, Amanda Mocroft, Helen Sambatakou, et al.
AIDS Research and Therapy|January 21, 2012
Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCGPhilip Hartjen, Sebastian Frerk, Ilona Hauber, et al.
Plos Pathogens|February 6, 2013
Functional characterization of HLA-G⁺ regulatory T cells in HIV-1 infectionChun Li, Ilona Toth, Julian Schulze Zur Wiesch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2015
Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot StudyJan van Lunzen, Anton Pozniak, Jose M Gatell, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2005
Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapyMikulas Popovic, Klara Tenner-Racz, Colleen Pelser, et al.
Antiviral Therapy|April 26, 2013
Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiativeAlison J Rodger, Tina Bruun, Pietro Vernazza, et al.
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Clinical Immunology (Orlando, Fla.)|May 10, 2003
The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDSMathias Lichterfeld, Hans Dieter Nischalke, Jan van Lunzen, et al.
Cytometry. Part B, Clinical Cytometry|December 16, 2015
Parallel assessment of Th17 cell frequencies by surface marker co-expression versus ex vivo IL-17 production in HIV-1 infectionGábor A Dunay, Ilona Tóth, Johanna M Eberhard, et al.
Plos One|June 19, 2010
Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patientsClara Lehmann, Mark Lafferty, Alfredo Garzino-Demo, et al.
The American Journal of Gastroenterology|June 30, 2005
Decline in esophageal candidiasis and use of antimycotics in European patients with HIVAmanda Mocroft, Cristina Oancea, Jan van Lunzen, et al.
AIDS (London, England)|November 5, 2008
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?Joanne Reekie, Amanda Mocroft, Helen Sambatakou, et al.
AIDS Research and Therapy|January 21, 2012
Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCGPhilip Hartjen, Sebastian Frerk, Ilona Hauber, et al.
Plos Pathogens|February 6, 2013
Functional characterization of HLA-G⁺ regulatory T cells in HIV-1 infectionChun Li, Ilona Toth, Julian Schulze Zur Wiesch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2015
Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot StudyJan van Lunzen, Anton Pozniak, Jose M Gatell, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2005
Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapyMikulas Popovic, Klara Tenner-Racz, Colleen Pelser, et al.
Antiviral Therapy|April 26, 2013
Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiativeAlison J Rodger, Tina Bruun, Pietro Vernazza, et al.
Pageof 12